Computational approaches in cancer multidrug resistance research: Identification of potential biomarkers, drug targets and drug-target interactions.

Like physics in the 19th century, biology and molecular biology in particular, has been fertilized and enhanced like few other scientific fields, by the incorporation of mathematical methods. In the last decades, a whole new scientific field, bioinformatics, has developed with an output of over 30,000 papers a year (Pubmed search using the keyword "bioinformatics"). Huge databases of mass throughput data have been established, with ArrayExpress alone containing more than 2.7 million assays (October 2019). Computational methods have become indispensable tools in molecular biology, particularly in one of the most challenging areas of cancer research, multidrug resistance (MDR). However, confronted with a plethora of different algorithms, approaches, and methods, the average researcher faces key questions: Which methods do exist? Which methods can be used to tackle the aims of a given study? Or, more generally, how do I use computational biology/bioinformatics to bolster my research? The current review is aimed at providing guidance to existing methods with relevance to MDR research. In particular, we provide an overview on: a) the identification of potential biomarkers using expression data; b) the prediction of treatment response by machine learning methods; c) the employment of network approaches to identify gene/protein regulatory networks and potential key players; d) the identification of drug-target interactions; e) the use of bipartite networks to identify multidrug targets; f) the identification of cellular subpopulations with the MDR phenotype; and, finally, g) the use of molecular modeling methods to guide and enhance drug discovery. This review shall serve as a guide through some of the basic concepts useful in MDR research. It shall give the reader some ideas about the possibilities in MDR research by using computational tools, and, finally, it shall provide a short overview of relevant literature.

[1]  S. Stigler Gauss and the Invention of Least Squares , 1981 .

[2]  E. Diamandis,et al.  Cancer biomarkers: can we turn recent failures into success? , 2010, Journal of the National Cancer Institute.

[3]  S. Aller,et al.  Allosteric Role of Substrate Occupancy Toward the Alignment of P-glycoprotein Nucleotide Binding Domains , 2018, Scientific Reports.

[4]  Robert Clarke,et al.  Differential dependency network analysis to identify condition-specific topological changes in biological networks , 2009, Bioinform..

[5]  M. Care,et al.  Parsimonious Gene Correlation Network Analysis (PGCNA): a tool to define modular gene co-expression for refined molecular stratification in cancer , 2019, npj Systems Biology and Applications.

[6]  Genwei Zhang,et al.  Towards rapid prediction of drug-resistant cancer cell phenotypes: single cell mass spectrometry combined with machine learning. , 2019, Chemical communications.

[7]  Yingzi Wang,et al.  Epithelial-mesenchymal transition markers screened in a cell-based model and validated in lung adenocarcinoma , 2019, BMC Cancer.

[8]  Y. Zhang,et al.  IntAct—open source resource for molecular interaction data , 2006, Nucleic Acids Res..

[9]  M. Gottesman,et al.  Revisiting the role of ABC transporters in multidrug-resistant cancer , 2018, Nature Reviews Cancer.

[10]  Ricardo J. Ferreira,et al.  Molecular Docking Characterizes Substrate-Binding Sites and Efflux Modulation Mechanisms within P-Glycoprotein , 2013, J. Chem. Inf. Model..

[11]  Robert Tibshirani,et al.  The Elements of Statistical Learning: Data Mining, Inference, and Prediction, 2nd Edition , 2001, Springer Series in Statistics.

[12]  Shashank Kumar,et al.  Emerging targets in cancer drug resistance , 2019, Cancer drug resistance.

[13]  Y. Assaraf,et al.  Targeted nanomedicine for cancer therapeutics: Towards precision medicine overcoming drug resistance. , 2017, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[14]  Hassane S. Mchaourab,et al.  On the Origin of Large Flexibility of P-glycoprotein in the Inward-facing State* , 2013, The Journal of Biological Chemistry.

[15]  R. Fisher THE USE OF MULTIPLE MEASUREMENTS IN TAXONOMIC PROBLEMS , 1936 .

[16]  Eric P. Xing,et al.  Network Analysis of Breast Cancer Progression and Reversal Using a Tree-Evolving Network Algorithm , 2014, PLoS Comput. Biol..

[17]  Max Kuhn,et al.  caret: Classification and Regression Training , 2015 .

[18]  Sarah A Heerboth,et al.  Drug Resistance in Cancer: An Overview , 2014, Cancers.

[19]  Tianyang Sun,et al.  Drug promiscuity of P-glycoprotein and its mechanism of interaction with paclitaxel and doxorubicin. , 2014, Soft matter.

[20]  A. Scorilas,et al.  High microRNA-28-5p expression in colorectal adenocarcinoma predicts short-term relapse of node-negative patients and poor overall survival of patients with non-metastatic disease , 2018, Clinical chemistry and laboratory medicine.

[21]  S. Horvath,et al.  A General Framework for Weighted Gene Co-Expression Network Analysis , 2005, Statistical applications in genetics and molecular biology.

[22]  Yidong Chen,et al.  scdNet: a computational tool for single-cell differential network analysis , 2018, BMC Systems Biology.

[23]  G. Yousef,et al.  Gemcitabine impacts differentially on bladder and kidney cancer cells: distinct modulations in the expression patterns of apoptosis-related microRNAs and BCL2 family genes , 2015, Tumor Biology.

[24]  K. Berka,et al.  Structural patterns of the human ABCC4/MRP4 exporter in lipid bilayers rationalize clinically observed polymorphisms , 2018, Pharmacological Research.

[25]  T. Mohr,et al.  Proteome profiling in IL-1β and VEGF-activated human umbilical vein endothelial cells delineates the interlink between inflammation and angiogenesis , 2017, PloS one.

[26]  S. Horvath Weighted Network Analysis: Applications in Genomics and Systems Biology , 2011 .

[27]  Sung Young Kim,et al.  Prediction of Acquired Taxane Resistance Using a Personalized Pathway-Based Machine Learning Method , 2018, Cancer research and treatment : official journal of Korean Cancer Association.

[28]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[29]  Lin Song,et al.  Comparison of co-expression measures: mutual information, correlation, and model based indices , 2012, BMC Bioinformatics.

[30]  E. Lindahl,et al.  Membrane proteins: molecular dynamics simulations. , 2008, Current opinion in structural biology.

[31]  Thalia E. Chan,et al.  Gene Regulatory Network Inference from Single-Cell Data Using Multivariate Information Measures , 2016, bioRxiv.

[32]  Eivind Hovig,et al.  Predicting Physical Interactions between Protein Complexes* , 2013, Molecular & Cellular Proteomics.

[33]  Marcus W Beck,et al.  NeuralNetTools: Visualization and Analysis Tools for Neural Networks. , 2018, Journal of statistical software.

[34]  L. Scott Larotrectinib: First Global Approval , 2019, Drugs.

[35]  F. Meric-Bernstam,et al.  Challenges with biomarkers in cancer drug discovery and development , 2018, Expert opinion on drug discovery.

[36]  Hui Zhang,et al.  A prediction model of substrates and non-substrates of breast cancer resistance protein (BCRP) developed by GA-CG-SVM method , 2011, Comput. Biol. Medicine.

[37]  A. Barabasi,et al.  Drug—target network , 2007, Nature Biotechnology.

[38]  Xinyi Liu,et al.  Deep-Resp-Forest: A deep forest model to predict anti-cancer drug response. , 2019, Methods.

[39]  A. Barabasi,et al.  Network biology: understanding the cell's functional organization , 2004, Nature Reviews Genetics.

[40]  Giovanni Iacono,et al.  Single-Cell Transcriptomics Unveils Gene Regulatory Network Plasticity , 2018 .

[41]  Y. Assaraf,et al.  Modulating ROS to overcome multidrug resistance in cancer. , 2018, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[42]  Ruo-Pan Huang,et al.  Cytokines in cancer drug resistance: Cues to new therapeutic strategies. , 2016, Biochimica et biophysica acta.

[43]  Tingting Fu,et al.  Therapeutic target database update 2018: enriched resource for facilitating bench-to-clinic research of targeted therapeutics , 2017, Nucleic Acids Res..

[44]  Funda Meric-Bernstam,et al.  Building a personalized medicine infrastructure at a major cancer center. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[45]  Ingebrigt Sylte,et al.  Theoretical Biology and Medical Modelling Open Access Binding Site of Abc Transporter Homology Models Confirmed by Abcb1 Crystal Structure , 2022 .

[46]  Ashutosh Singh,et al.  Targeting Nucleotide Binding Domain of Multidrug Resistance-associated Protein-1 (MRP1) for the Reversal of Multi Drug Resistance in Cancer , 2018, Scientific Reports.

[47]  Henning Hermjakob,et al.  The Reactome pathway Knowledgebase , 2015, Nucleic acids research.

[48]  A. Scorilas,et al.  Unraveling UCA1 lncRNA prognostic utility in urothelial bladder cancer. , 2019, Carcinogenesis.

[49]  Luis Rueda Microarray Image and Data Analysis : Theory and Practice , 2018 .

[50]  Ash A. Alizadeh,et al.  Robust enumeration of cell subsets from tissue expression profiles , 2015, Nature Methods.

[51]  Qing Zhao,et al.  Deciphering the associations between gene expression and copy number alteration using a sparse double Laplacian shrinkage approach , 2015, Bioinform..

[52]  Arvind K. Bansal,et al.  In silico model for P-glycoprotein substrate prediction: insights from molecular dynamics and in vitro studies , 2013, Journal of Computer-Aided Molecular Design.

[53]  Lili Liu,et al.  Selective reversal of BCRP‐mediated MDR by VEGFR‐2 inhibitor ZM323881 , 2017, Biochemical pharmacology.

[54]  Carlos Prieto,et al.  APID: Agile Protein Interaction DataAnalyzer , 2006, Nucleic Acids Res..

[55]  Septimiu E. Salcudean,et al.  Comparison of Artificial Intelligence Techniques to Evaluate Performance of a Classifier for Automatic Grading of Prostate Cancer From Digitized Histopathologic Images , 2019, JAMA network open.

[56]  Deng Pan,et al.  DGIdb 2.0: mining clinically relevant drug–gene interactions , 2015, Nucleic Acids Res..

[57]  A. Scorilas,et al.  miR-224 overexpression is a strong and independent prognosticator of short-term relapse and poor overall survival in colorectal adenocarcinoma. , 2015, International journal of oncology.

[58]  L Zhang,et al.  Emerging Transporters of Clinical Importance: An Update From the International Transporter Consortium , 2013, Clinical pharmacology and therapeutics.

[59]  J. Kowal,et al.  Structural insight into substrate and inhibitor discrimination by human P-glycoprotein , 2019, Science.

[60]  J. Lee,et al.  Single-cell analysis of a mutant library generated using CRISPR-guided deaminase in human melanoma cells , 2019, Communications Biology.

[61]  Min Zhang,et al.  Systematic identification of non-coding pharmacogenomic landscape in cancer , 2018, Nature Communications.

[62]  Duhee Bang,et al.  Multiplexed single-cell RNA-seq via transient barcoding for simultaneous expression profiling of various drug perturbations , 2019, Science Advances.

[63]  K. Ogawa,et al.  Mechanisms of Resistance to Kinase Inhibitors and Strategies to Prevent the Development of Drug Resistance , 2018 .

[64]  I. Amit,et al.  Dissecting Immune Circuits by Linking CRISPR-Pooled Screens with Single-Cell RNA-Seq , 2016, Cell.

[65]  Gerhard F. Ecker,et al.  Prediction of drug–ABC-transporter interaction — Recent advances and future challenges☆ , 2015, Advanced drug delivery reviews.

[66]  Maria P. Pavlou,et al.  Integrating high-throughput technologies in the quest for effective biomarkers for ovarian cancer , 2010, Nature Reviews Cancer.

[67]  O. Firuzi,et al.  Molecular dynamics simulation and molecular docking studies of 1,4-Dihydropyridines as P-glycoprotein’s allosteric inhibitors , 2018, Journal of biomolecular structure & dynamics.

[68]  Luciana Gavernet,et al.  Docking Applied to the Prediction of the Affinity of Compounds to P-Glycoprotein , 2014, BioMed research international.

[69]  Yufei Huang,et al.  Predicting drug response of tumors from integrated genomic profiles by deep neural networks , 2018, BMC Medical Genomics.

[70]  Jie Tang,et al.  Environmental Research and Public Health Long Non-coding Rna as Potential Biomarker for Prostate Cancer: Is It Making a Difference? , 2022 .

[71]  Ricardo J. Ferreira,et al.  Structure-function relationships in ABCG2: insights from molecular dynamics simulations and molecular docking studies , 2017, Scientific Reports.

[72]  E. Nice,et al.  Proteogenomic studies on cancer drug resistance: towards biomarker discovery and target identification , 2017, Expert review of proteomics.

[73]  F. Zunino,et al.  Overview of tumor cell chemoresistance mechanisms. , 2005, Methods in molecular medicine.

[74]  L. Monticelli,et al.  Calculating the free energy of transfer of small solutes into a model lipid membrane: Comparison between metadynamics and umbrella sampling. , 2015, The Journal of chemical physics.

[75]  Othman Soufan,et al.  NetworkAnalyst 3.0: a visual analytics platform for comprehensive gene expression profiling and meta-analysis , 2019, Nucleic Acids Res..

[76]  Zhe-Sheng Chen,et al.  Dacomitinib antagonizes multidrug resistance (MDR) in cancer cells by inhibiting the efflux activity of ABCB1 and ABCG2 transporters. , 2018, Cancer letters.

[77]  E. Pardon,et al.  Structures of P-glycoprotein reveal its conformational flexibility and an epitope on the nucleotide-binding domain , 2013, Proceedings of the National Academy of Sciences.

[78]  Yehuda G Assaraf,et al.  Antifolates in cancer therapy: structure, activity and mechanisms of drug resistance. , 2012, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[79]  K. Kuchler,et al.  The structure of the human ABC transporter ABCG2 reveals a novel mechanism for drug extrusion , 2017, Scientific Reports.

[80]  E. Krieger,et al.  Phenylalanine 368 of multidrug resistance-associated protein 4 (MRP4/ABCC4) plays a crucial role in substrate-specific transport activity. , 2012, Biochemical pharmacology.

[81]  Ziv Bar-Joseph,et al.  Network-guided prediction of aromatase inhibitor response in breast cancer , 2019, PLoS Comput. Biol..

[82]  C. Etchebest,et al.  New insights into GluT1 mechanics during glucose transfer , 2019, Scientific Reports.

[83]  J. Stanton Galton, Pearson, and the Peas: A Brief History of Linear Regression for Statistics Instructors , 2001 .

[84]  Su-In Lee,et al.  A machine learning approach to integrate big data for precision medicine in acute myeloid leukemia , 2018, Nature Communications.

[85]  J. F. Wang,et al.  Prediction of P-Glycoprotein Substrates by a Support Vector Machine Approach , 2004, J. Chem. Inf. Model..

[86]  I. Gould,et al.  Modeling the Effect of BSEP Inhibitors in Lipid Bilayers by Means of All-Atom Molecular Dynamics Simulation , 2019, ACS Omega.

[87]  Gerhard F Ecker,et al.  Predicting drug resistance related to ABC transporters using unsupervised Consensus Self-Organizing Maps , 2018, Scientific Reports.

[88]  E. Giovannetti,et al.  A mechanopharmacology approach to overcome chemoresistance in pancreatic cancer. , 2017, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[89]  Chris Wiggins,et al.  ARACNE: An Algorithm for the Reconstruction of Gene Regulatory Networks in a Mammalian Cellular Context , 2004, BMC Bioinformatics.

[90]  Leo Breiman,et al.  Random Forests , 2001, Machine Learning.

[91]  Andreas Krämer,et al.  Causal analysis approaches in Ingenuity Pathway Analysis , 2013, Bioinform..

[92]  K. Berka,et al.  Behavior of human cytochromes P450 on lipid membranes. , 2013, The journal of physical chemistry. B.

[93]  Justin Guinney,et al.  Systematic Assessment of Analytical Methods for Drug Sensitivity Prediction from Cancer Cell Line Data , 2013, Pacific Symposium on Biocomputing.

[94]  Y. Assaraf,et al.  Structure and Function of ABCG2-Rich Extracellular Vesicles Mediating Multidrug Resistance , 2011, PloS one.

[95]  Diego Alonso-López,et al.  Human Interactomics: Comparative Analysis of Different Protein Interaction Resources and Construction of a Cancer Protein-Drug Bipartite Network. , 2018, Advances in protein chemistry and structural biology.

[96]  Y. Assaraf,et al.  Repositioning of drugs for intervention in tumor progression and metastasis: Old drugs for new targets. , 2016, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[97]  Y. Assaraf,et al.  Novel extracellular vesicles mediate an ABCG2-dependent anticancer drug sequestration and resistance. , 2005, Cancer research.

[98]  Julia M. Barbarino,et al.  PharmGKB: A worldwide resource for pharmacogenomic information , 2018, Wiley interdisciplinary reviews. Systems biology and medicine.

[99]  E. Hovig,et al.  Differential Protein Network Analysis of the Immune Cell Lineage , 2014, BioMed research international.

[100]  Carlos Prieto,et al.  APID interactomes: providing proteome-based interactomes with controlled quality for multiple species and derived networks , 2016, Nucleic Acids Res..

[101]  Ting Gong,et al.  DeconRNASeq: a statistical framework for deconvolution of heterogeneous tissue samples based on mRNA-Seq data , 2013, Bioinform..

[102]  J. S. Cramer The Origins of Logistic Regression , 2002 .

[103]  K. Schulten,et al.  Permeability of a Fluid Lipid Bilayer to Short-Chain Alcohols from First Principles. , 2017, Journal of chemical theory and computation.

[104]  T. Oguri,et al.  Genetic variation in the ATP binding cassette transporter ABCC10 is associated with neutropenia for docetaxel in Japanese lung cancer patients cohort , 2019, BMC Cancer.

[105]  Davide Heller,et al.  STRING v10: protein–protein interaction networks, integrated over the tree of life , 2014, Nucleic Acids Res..

[106]  Katherina Baranova,et al.  Genomic signatures for paclitaxel and gemcitabine resistance in breast cancer derived by machine learning , 2016, Molecular oncology.

[107]  Xander A A M Verbeek,et al.  Transformation of the National Breast Cancer Guideline Into Data-Driven Clinical Decision Trees. , 2019, JCO clinical cancer informatics.

[108]  L. O’Driscoll,et al.  Isolation from a human MDR lung cell line of multiple clonal subpopulations which exhibit significantly different drug resistance , 1997, International journal of cancer.

[109]  Johannes Zuber,et al.  Coupling shRNA screens with single-cell RNA-seq identifies a dual role for mTOR in reprogramming-induced senescence , 2017, Genes & development.

[110]  Yunming Ye,et al.  Deconvolution of single-cell multi-omics layers reveals regulatory heterogeneity , 2018, Nature Communications.

[111]  Mahmoud Moradi,et al.  Mechanistic picture for conformational transition of a membrane transporter at atomic resolution , 2013, Proceedings of the National Academy of Sciences.

[112]  R. Nitsch,et al.  CRISPR-UMI: single-cell lineage tracing of pooled CRISPR–Cas9 screens , 2017, Nature Methods.

[113]  Leo Breiman,et al.  Statistical Modeling: The Two Cultures (with comments and a rejoinder by the author) , 2001 .

[114]  Nandhitha Subramanian,et al.  Probing the Pharmacological Binding Sites of P-Glycoprotein Using Umbrella Sampling Simulations , 2018, J. Chem. Inf. Model..

[115]  Per Artursson,et al.  Expression of Thirty-six Drug Transporter Genes in Human Intestine, Liver, Kidney, and Organotypic Cell Lines , 2007, Drug Metabolism and Disposition.

[116]  Hisanori Kiryu,et al.  SCODE: an efficient regulatory network inference algorithm from single-cell RNA-Seq during differentiation , 2016, bioRxiv.

[117]  Y. Assaraf,et al.  Microenvironment acidity as a major determinant of tumor chemoresistance: Proton pump inhibitors (PPIs) as a novel therapeutic approach. , 2015, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[118]  V. Koshkin,et al.  Single-cell-kinetics approach to compare multidrug resistance-associated membrane transport in subpopulations of cells. , 2011, Analytical chemistry.

[119]  Ricardo J. Ferreira,et al.  Reversing cancer multidrug resistance: insights into the efflux by ABC transports from in silico studies , 2015 .

[120]  M. Zloh,et al.  Computational classification models for predicting the interaction of drugs with P-glycoprotein and breast cancer resistance protein , 2014, SAR and QSAR in environmental research.

[121]  M. O'Kane,et al.  Practical guide for identifying unmet clinical needs for biomarkers , 2018, EJIFCC.

[122]  Arieh Warshel,et al.  ZnT2 is an electroneutral proton-coupled vesicular antiporter displaying an apparent stoichiometry of two protons per zinc ion , 2019, PLoS Comput. Biol..

[123]  A. Ravna,et al.  Molecular model of the outward facing state of the human multidrug resistance protein 4 (MRP4/ABCC4). , 2008, Bioorganic & medicinal chemistry letters.

[124]  Jing Wang,et al.  WebGestalt 2017: a more comprehensive, powerful, flexible and interactive gene set enrichment analysis toolkit , 2017, Nucleic Acids Res..

[125]  Thomas M. Norman,et al.  Perturb-Seq: Dissecting Molecular Circuits with Scalable Single-Cell RNA Profiling of Pooled Genetic Screens , 2016, Cell.

[126]  Viktor Hornak,et al.  Structure-Kinetic Relationships of Passive Membrane Permeation from Multiscale Modeling. , 2017, Journal of the American Chemical Society.

[127]  Sung Young Kim,et al.  Machine learning identifies a core gene set predictive of acquired resistance to EGFR tyrosine kinase inhibitor , 2018, Journal of Cancer Research and Clinical Oncology.

[128]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[129]  Yiyu Cheng,et al.  Identifying P-Glycoprotein Substrates Using a Support Vector Machine Optimized by a Particle Swarm , 2007, J. Chem. Inf. Model..

[130]  Y. Assaraf,et al.  Imidazoacridinone-dependent lysosomal photodestruction: a pharmacological Trojan horse approach to eradicate multidrug-resistant cancers , 2012, Cell Death and Disease.

[131]  Riccardo Zecchina,et al.  A Prize-Collecting Steiner Tree Approach for Transduction Network Inference , 2009, CMSB.

[132]  Michael Hecker,et al.  Gene regulatory network inference: Data integration in dynamic models - A review , 2009, Biosyst..

[133]  Fabian J Theis,et al.  Computational analysis of cell-to-cell heterogeneity in single-cell RNA-sequencing data reveals hidden subpopulations of cells , 2015, Nature Biotechnology.

[134]  Michael K. Gilson,et al.  BindingDB in 2015: A public database for medicinal chemistry, computational chemistry and systems pharmacology , 2015, Nucleic Acids Res..

[135]  Daniel F Hayes,et al.  Cancer biomarkers , 2012, Molecular oncology.

[136]  P. Souček,et al.  ABC gene expression profiles have clinical importance and possibly form a new hallmark of cancer , 2017, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

[137]  A. Schlessinger,et al.  Molecular Modeling of Drug–Transporter Interactions—An International Transporter Consortium Perspective , 2018, Clinical pharmacology and therapeutics.

[138]  E. Giovannetti,et al.  Molecular basis and rationale for combining immune checkpoint inhibitors with chemotherapy in non-small cell lung cancer. , 2019, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[139]  P. Biggin,et al.  Towards understanding promiscuity in multidrug efflux pumps. , 2014, Trends in biochemical sciences.

[140]  Joanna L. Sharman,et al.  The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands , 2015, Nucleic Acids Res..

[141]  Nancy R. Zhang,et al.  Bulk tissue cell type deconvolution with multi-subject single-cell expression reference , 2018, Nature Communications.

[142]  Rosalinde Masereeuw,et al.  Multidrug resistance protein 4 (MRP4/ABCC4): a versatile efflux transporter for drugs and signalling molecules. , 2008, Trends in pharmacological sciences.

[143]  Somnath Datta,et al.  Integrating gene regulatory pathways into differential network analysis of gene expression data , 2019, Scientific Reports.

[144]  A. Scorilas,et al.  miRNA and long non-coding RNA: molecular function and clinical value in breast and ovarian cancers , 2018, Expert review of molecular diagnostics.

[145]  Brian D. Ripley,et al.  Modern Applied Statistics with S Fourth edition , 2002 .

[146]  Kurt Hornik,et al.  Multilayer feedforward networks are universal approximators , 1989, Neural Networks.

[147]  Karthik Raman,et al.  The organisational structure of protein networks: revisiting the centrality–lethality hypothesis , 2013, Systems and Synthetic Biology.

[148]  Jue Chen,et al.  Crystal structure of the multidrug transporter P-glycoprotein from C. elegans , 2012, Nature.

[149]  Q. Cui,et al.  A Network of Cancer Genes with Co-Occurring and Anti-Co-Occurring Mutations , 2010, PloS one.

[150]  Y. Assaraf,et al.  Overcoming ABC transporter-mediated multidrug resistance: Molecular mechanisms and novel therapeutic drug strategies. , 2016, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[151]  A. di Pietro,et al.  Localization of putative binding sites for cyclic guanosine monophosphate and the anti-cancer drug 5-fluoro-2′-deoxyuridine-5′-monophosphate on ABCC11 in silico models , 2013, BMC Structural Biology.

[152]  T. Jenssen,et al.  A literature network of human genes for high-throughput analysis of gene expression , 2001, Nature Genetics.

[153]  G. Várady,et al.  Clinically relevant mutations in the ABCG2 transporter uncovered by genetic analysis linked to erythrocyte membrane protein expression , 2018, Scientific Reports.

[154]  G. Coukos,et al.  Personalized approaches to active immunotherapy in cancer. , 2016, Biochimica et biophysica acta.

[155]  Robert O'Connor,et al.  Drug resistance in cancer – searching for mechanisms, markers and therapeutic agents , 2007, Expert opinion on drug metabolism & toxicology.

[156]  S. Sardari,et al.  Informatics of drug synergism in naturally occurring anticancer agents. , 2011, Recent patents on anti-cancer drug discovery.

[157]  S. W. Lee,et al.  Acral melanoma detection using a convolutional neural network for dermoscopy images , 2018, PloS one.

[158]  Jianping Zhou,et al.  Mechanisms of TPGS and its derivatives inhibiting P-glycoprotein efflux pump and application for reversing multidrug resistance in hepatocellular carcinoma , 2018 .

[159]  Pedro J. Ballester,et al.  Precision and recall oncology: combining multiple gene mutations for improved identification of drug-sensitive tumours , 2017, Oncotarget.

[160]  G. Yousef,et al.  Cytotoxic activity of sunitinib and everolimus in Caki-1 renal cancer cells is accompanied by modulations in the expression of apoptosis-related microRNA clusters and BCL2 family genes. , 2015, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[161]  Carlton Anthony Taft and Carlos Henrique Tomich de Paula d Silva Cancer and Aids: New Trends in Drug Design and Chemotherapy , 2006 .

[162]  Jianing Song,et al.  Insights on Na+ binding and conformational dynamics in multidrug and toxic compound extrusion transporter NorM , 2014, Proteins.

[163]  Nicholas J Provart,et al.  Analyses of Protein Interaction Networks Using Computational Tools. , 2018, Methods in molecular biology.

[164]  A. Tiwari,et al.  Cariprazine, A Dopamine D2/D3 Receptor Partial Agonist, Modulates ABCG2-Mediated Multidrug Resistance in Cancer , 2018, Cancers.

[165]  R. Kim,et al.  The Role of Next-Generation Sequencing in Pharmacogenetics and Pharmacogenomics. , 2018, Cold Spring Harbor perspectives in medicine.

[166]  D. M. Vera,et al.  Binding of modulators to mouse and human multidrug resistance P-glycoprotein. A computational study. , 2013, Journal of molecular graphics & modelling.

[167]  Won-Ho Shin,et al.  Deep learning of mutation-gene-drug relations from the literature , 2017, BMC Bioinformatics.

[168]  Jean-Pierre Gillet,et al.  Mechanisms of multidrug resistance in cancer. , 2010, Methods in molecular biology.

[169]  A. Barabasi,et al.  Lethality and centrality in protein networks , 2001, Nature.

[170]  M Michael Gromiha,et al.  Drug-Target Interactions: Prediction Methods and Applications. , 2018, Current protein & peptide science.

[171]  D. Tieleman,et al.  Coarse-grained molecular dynamics simulations reveal lipid access pathways in P-glycoprotein , 2018, The Journal of general physiology.

[172]  A. C. Gasparovic,et al.  What sustains the multidrug resistance phenotype beyond ABC efflux transporters? Looking beyond the tip of the iceberg. , 2019, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[173]  Barbara Zdrazil,et al.  Selectivity profiling of BCRP versus P-gp inhibition: from automated collection of polypharmacology data to multi-label learning , 2016, Journal of Cheminformatics.

[174]  S. Horvath,et al.  Protein expression based multimarker analysis of breast cancer samples , 2011, BMC Cancer.

[175]  Arieh Warshel,et al.  Demonstrating aspects of multiscale modeling by studying the permeation pathway of the human ZnT2 zinc transporter , 2018, PLoS Comput. Biol..

[176]  André F. Rendeiro,et al.  Pooled CRISPR screening with single-cell transcriptome read-out , 2017, Nature Methods.

[177]  Bernd Bischl,et al.  mlr: Machine Learning in R , 2016, J. Mach. Learn. Res..

[178]  Gaël Varoquaux,et al.  Scikit-learn: Machine Learning in Python , 2011, J. Mach. Learn. Res..

[179]  Jihye Kim,et al.  DSigDB: drug signatures database for gene set analysis , 2015, Bioinform..

[180]  A. Fernández-Medarde,et al.  Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy. , 2015, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[181]  Thomas Girke,et al.  systemPipeR: NGS workflow and report generation environment , 2016, BMC Bioinformatics.

[182]  Y. Assaraf,et al.  Lysosomes as mediators of drug resistance in cancer. , 2016, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[183]  A. Mai,et al.  Epigenetic polypharmacology: A new frontier for epi‐drug discovery , 2020, Medicinal research reviews.

[184]  Georg Heinze,et al.  Variable selection – A review and recommendations for the practicing statistician , 2018, Biometrical journal. Biometrische Zeitschrift.

[185]  Davis J. McCarthy,et al.  f-scLVM: scalable and versatile factor analysis for single-cell RNA-seq , 2017, Genome Biology.

[186]  G. Ecker,et al.  Predicting Ligand Interactions with ABC Transporters in ADME , 2009, Chemistry & biodiversity.

[187]  Alexey I. Nesvizhskii,et al.  Reconstructing targetable pathways in lung cancer by integrating diverse omics data , 2013, Nature Communications.

[188]  Y. Assaraf,et al.  The multi-factorial nature of clinical multidrug resistance in cancer. , 2019, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[189]  S. Horvath,et al.  Analysis of oncogenic signaling networks in glioblastoma identifies ASPM as a molecular target , 2006, Proceedings of the National Academy of Sciences.

[190]  E. Krieger,et al.  Functional Role of Arginine 375 in Transmembrane Helix 6 of Multidrug Resistance Protein 4 (MRP4/ABCC4) , 2008, Molecular Pharmacology.